Last reviewed · How we verify
NCT03117556
Bilateral Thoracoscopic Splanchnicectomy for Pain Relief in Patients With Unresectable Pancreatic Cancer
NA trial testing Bilateral Thoracoscopic Splanchnicectomy in Unresectable Pancreatic Cancer. Withdrawn.
16 April 2018
Quick facts
| Lead sponsor | University of Louisville |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Start date | 31 August 2017 |
| Primary completion | 16 April 2018 |
| Estimated completion | 16 April 2018 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Bilateral Thoracoscopic Splanchnicectomy
Conditions studied
- Unresectable Pancreatic Cancer — all drugs for Unresectable Pancreatic Cancer →
Sponsor
University of Louisville
Who can join
18 and older, any sex, with Unresectable Pancreatic Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to compare the efficacy of bilateral thoracoscopic splanchnicectomy (BTS) to conventional narcotic analgesia for control of abdominal pain in patients with pancreatic ductal adenocarcinoma not amenable to surgical resection.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03117556
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Unresectable Pancreatic Cancer
Currently open trials in the same condition.
- NCT07198659 — A Single-Arm Investigator-Initiated Tria (IIT) Evaluating the Safety and Preliminary Efficacy of Autologous Drug-Loaded · EARLY_PHASE1 · recruiting
- NCT06135896 — Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers · Phase 2 · recruiting
- NCT05601323 — A Study of Suizenji in Patients With Unresectable Pancreatic Cancer · NA · active not recruiting
- NCT04789486 — Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer · Phase 1, PHASE2 · recruiting
- NCT03138720 — Pre-operative Treatment for Patients With Untreated Pancreatic Cancer · Phase 2 · active not recruiting
Other University of Louisville trials
Trials by the same sponsor.
- NCT07219888 — Comparison of Suzetrigine and Oxycodone for Postoperative Pain After Primary Total Knee Arthroplasty · Phase 4 · not yet recruiting
- NCT07044726 — Betadine vs Sterile Water for Periurethral Preparation · Phase 4 · not yet recruiting
- NCT06489106 — Noninvasive Spinal Stimulation to Restore Hand Function in Children With Spinal Cord Injury · NA · enrolling by invitation
- NCT06883513 — Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID · NA · recruiting
- NCT05920720 — Self-Guided Personalized Treatment for Women · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03117556 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Louisville
- Last refreshed: 21 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03117556.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing